PREMISES 1. WITNESSETH: That Lessor hereby leases to Lessee, and Lessee hires from Lessor, those certain premises, hereinafter in this lease designated as "the Premises", with the appurtenances, situated in the City of Mountain View, County of Santa...Lease Agreement • March 28th, 2003 • Iridex Corp • Electromedical & electrotherapeutic apparatus
AGREEMENT ---------Change of Control Agreement • August 12th, 2003 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
LEASE AGREEMENTLease Agreement • November 12th, 2003 • Iridex Corp • Electromedical & electrotherapeutic apparatus
1 Exhibit 10.7 BUSINESS LOAN AGREEMENTBusiness Loan Agreement • March 31st, 1998 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 3rd, 2016 • Iridex Corp • Electromedical & electrotherapeutic apparatus • Delaware
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of November 2, 2016 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and IRIDEX CORPORATION, a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • June 16th, 2010 • Iridex Corp • Electromedical & electrotherapeutic apparatus • Delaware
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of June 11, 2010 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and IRIDEX CORPORATION, a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
IRIDEX CORPORATION UNDERWRITING AGREEMENT 1,150,000 Shares of Common StockUnderwriting Agreement • December 14th, 2016 • Iridex Corp • Electromedical & electrotherapeutic apparatus • New York
IRIDEX Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) an aggregate of 1,150,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.01 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional 172,500 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares.”
1,666,667 Shares IRIDEX CORPORATION Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 18th, 2018 • Iridex Corp • Electromedical & electrotherapeutic apparatus • New York
IRIDEX Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”) an aggregate of 1,666,667 shares (the “Firm Shares”) of the common stock, par value $0.01 per share, of the Company (“Common Stock”). The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, exercisable for 30 days from the date of the Prospectus (as defined below), up to an additional 250,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
IRIDEX CORPORATIONRestricted Stock Unit Award Agreement • August 4th, 2011 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
Unless otherwise defined herein, the terms defined in the IRIDEX Corporation (the “Company”) 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Award Agreement (the “Award Agreement”).
IRIDEX CORPORATIONRestricted Stock Award Agreement • August 4th, 2011 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
Unless otherwise defined herein, the terms defined in the IRIDEX Corporation 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Award Agreement (the “Award Agreement”).
IRIDEX CORPORATIONStock Option Award Agreement • November 21st, 2008 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
Unless otherwise defined herein, the terms defined in the IRIDEX Corporation 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Stock Option Award Agreement (the “Award Agreement”).
IRIDEX CORPORATION AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • November 13th, 2024 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Patrick Mercer (“Executive”) and IRIDEX Corporation, a Delaware corporation (the “Company”), effective as of October 30, 2024 (the “Effective Date”).
ContractWarrant Agreement • April 6th, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
THIS SECURITY AND ANY SHARES ISSUED UPON THE EXERCISE OR CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.
Triple Net LeaseTriple Net Lease • May 1st, 2017 • Iridex Corp • Electromedical & electrotherapeutic apparatus
This Lease is executed in duplicate in Mountain View, California, this 26th day of April, 2017, by and between ZIC 1212 Terra Bella LLC, a California limited liability company, and Iridex Corporation, a Delaware corporation, hereinafter referred to respectively as “Lessor” and “Lessee”, without regard to number or gender.
IRIDEX CORPORATION CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • April 1st, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This Change of Control Severance Agreement (the “Agreement”) is made and entered into by and between James H. Mackaness (“Executive”) and IRIDEX Corporation (the “Company”), effective as of January 22, 2008 (the “Effective Date”).
CREDIT AND SECURITY AGREEMENT (EX-IM SUBFACILITY)Credit and Security Agreement • April 2nd, 2008 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
THIS CREDIT AND SECURITY AGREEMENT (EX-IM SUBFACILITY) (THE “AGREEMENT”) IS DATED MARCH 27, 2008, AND IS ENTERED INTO BETWEEN IRIDEX CORPORATION, A DELAWARE CORPORATION (“COMPANY”), AND WELLS FARGO BANK, NATIONAL ASSOCIATION (AS MORE FULLY DEFINED IN EXHIBIT A, “WELLS FARGO”), ACTING THROUGH ITS WELLS FARGO BUSINESS CREDIT OPERATING DIVISION.
Export-Import Bank of the United States Working Capital Guarantee Program Borrower AgreementBorrower Agreement • April 2nd, 2008 • Iridex Corp • Electromedical & electrotherapeutic apparatus
THIS BORROWER AGREEMENT (this “Agreement”) is made and entered into by the entity identified as Borrower on the signature page hereof (“Borrower”) in favor of the Export-Import Bank of the United States (“Ex-Im Bank”) and the institution identified as Lender on the signature page hereof (“Lender”).
IRIDEX CORPORATION INDEMNIFICATION AGREEMENTIndemnification Agreement • March 15th, 2022 • Iridex Corp • Electromedical & electrotherapeutic apparatus • Delaware
This Indemnification Agreement (“Agreement”) is entered into effective as of [insert date], by and between IRIDEX Corporation, a Delaware corporation (the “Company”) and [insert name of indemnitee] (“Indemnitee”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 4th, 2021 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of March 2, 2021 (the “Agreement Date”) by and between IRIDEX Corporation, a Delaware corporation (“Acquiror”), and Topcon Medical Laser Systems, Inc., a California corporation (the “Company”, and collectively with Acquiror, the “Parties”), and, solely for the purpose of Section 11.15, Topcon America Corporation, a Delaware corporation (“Guarantor”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 8th, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus
This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 4th, 2021 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This Registration Rights Agreement (this “Agreement”) is dated as of March 2, 2021 by and between IRIDEX Corporation, a company duly incorporated and existing under the laws of the State of Delaware (the “Company”), and Topcon America Corporation, a company duly incorporated and existing under the laws of the State of Delaware (the “Investor”).
DISTRIBUTION AGREEMENTDistribution Agreement • March 4th, 2021 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This Distribution Agreement (this “Agreement”) is entered into as of March 2, 2021 by and between Iridex Corporation, a Delaware corporation with its principal place of business at 1212 Terra Bella Avenue, Mountain View, California 94043, United States (“Iridex”), and Topcon Corporation, a corporation organized under the laws of Japan with its principal place of business at 75-1 Hasunuma-cho, Itabashi-ku, Tokyo, Japan, 174-8580 (“Topcon”). Iridex and Topcon may be referred to herein by name or, individually, as a “Party” and, collectively, as the “Parties”.
ASSET PURCHASE AGREEMENT dated November 30, 2006 by and among AMERICAN MEDICAL SYSTEMS, INC., LASERSCOPE and IRIDEX CORPORATIONAsset Purchase Agreement • December 6th, 2006 • Iridex Corp • Electromedical & electrotherapeutic apparatus • New York
THIS ASSET PURCHASE AGREEMENT, dated November 30, 2006 (this “Agreement”), is by and among American Medical Systems, Inc., a Delaware corporation (“Parent”), Laserscope, a California corporation and a wholly owned subsidiary of Parent (“Seller”), and Iridex Corporation, a Delaware corporation (“Purchaser”). Capitalized terms used in this Agreement have the meanings provided in, or in such other sections hereof as are cross-referenced in, Article 10.
FIRST AMENDMENT TO BUSINESS LOAN AND SECURITY AGREEMENTBusiness Loan and Security Agreement • April 24th, 2007 • Iridex Corp • Electromedical & electrotherapeutic apparatus
This First Amendment (“First Amendment”) dated as of April 19, 2007, for reference purposes, is made to the BUSINESS LOAN AND SECURITY AGREEMENT (the “Domestic Agreement”) entered into as of January 16, 2007, by and between Mid-Peninsula Bank, part of Greater Bay Bank N.A. (“Bank”) and Iridex Corporation (“Borrower”), combining two credit facilities provided by Bank to Borrower, with one facility being a $6,000,000 principal amount asset-based revolving line of credit (“Line of Credit”) and the other facility being a $6,000,000 principal amount term loan (“Term Loan”).
FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENTS AND WAIVER OF DEFAULTCredit and Security Agreement • November 7th, 2008 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
THIS FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENTS AND WAIVER OF DEFAULT (this “Amendment”), dated November 3, 2008, is entered into by and between IRIDEX CORPORATION, a Delaware corporation (“Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (“Wells Fargo”), acting through its Wells Fargo Business Credit operating division.
IRIDEX CORPORATION AGREEMENT AND RELEASESeparation Agreement and Release • March 28th, 2013 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This Separation Agreement and Release (“Agreement”) is made by and between Dr. Dominik Beck (“Employee”) and IRIDEX Corporation (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) effective on the Effective Date (defined below).
FOURTH AMENDMENT TO LEASELease • March 31st, 2016 • Iridex Corp • Electromedical & electrotherapeutic apparatus
THIS FOURTH AMENDMENT TO LEASE (this “Amendment”) is dated as of January 31, 2016, and is entered into by and between Zappettini Investment Company, a California general partnership (“Lessor”), and IRIDEX Corporation (“Lessee”).
ASSET PURCHASE AGREEMENT by and between CUTERA, INC., a Delaware corporation, IRIDEX CORPORATION, a Delaware corporation, and as Escrow Agent Dated as of December 30, 2011Asset Purchase Agreement • January 4th, 2012 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of December 30, 2011 by and between, Cutera, Inc., a Delaware corporation (“Buyer”), IRIDEX Corporation, a Delaware corporation (the “Company”) and with respect to Article 7 hereof only, U.S. Bank National Association (the “Escrow Agent”).
SECOND AMENDMENT TO LEASELease • November 20th, 2023 • Iridex Corp • Electromedical & electrotherapeutic apparatus
THIS SECOND AMENDMENT TO LEASE (this “Amendment”) is dated for reference purposes only as of August 29, 2022, and is entered into by and between ZIC 1212 Terra Bella LLC, a Delaware limited liability company (“Lessor”), and IRIDEX CORPORATION, a Delaware corporation (“Lessee”), with regard to the following facts:
AMENDMENT NO. 1 TO INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • April 6th, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
THIS AMENDMENT NO. 1 TO INVESTOR RIGHTS AGREEMENT (this “Amendment”) is made and entered into as of March 31, 2009, by and among IRIDEX Corporation, a Delaware corporation (the “Company”) and the undersigned Holders. Any capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in that certain Investor Rights Agreement, dated as of August 31, 2007 (the “Agreement”), by and among the Company and each of BlueLine Capital Partners, LP, BlueLine Capital Partners II, LP and BlueLine Capital Partners III, LP.
10700 Bren Road West Minnetonka, MN 55343 USA Phone: 952-933-4666 Fax: 952-930-6157Product Supply Agreement • August 14th, 2007 • Iridex Corp • Electromedical & electrotherapeutic apparatus
This letter sets forth our mutual agreement with regard to: (a) the Product Supply Agreement, dated January 16, 2007, between Laserscope and Iridex Corporation (the “Supply Agreement”); (b) Iridex’s material, uncured breach of the Supply Agreement; and (c) the conditions under which Laserscope would agree not to exercise its right to terminate the Supply Agreement immediately.
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • November 13th, 2024 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
This Separation and Release Agreement (“Agreement”) is entered into by and between IRIDEX CORPORATION (defined to include its related organizations, foundations, subsidiaries, predecessors, successors, assigns, affiliates, and their respective officers, employees, ex-employees, and representatives and hereinafter referred as collectively as “IRIDEX” or the “Company”) and David I. Bruce (“Employee”). Employee and IRIDEX are referred to collectively herein as the Parties. This Agreement shall be effective as of the date the revocation period expires, if Employee has not revoked the Agreement (“Effective Date”).
IRIDEX CORPORATION STAND-ALONE STOCK OPTION AGREEMENTStand-Alone Stock Option Agreement • July 30th, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
THIRD AMENDMENT TO LEASELease • November 20th, 2023 • Iridex Corp • Electromedical & electrotherapeutic apparatus
THIS THIRD AMENDMENT TO LEASE (this “Amendment”) is dated for reference purposes only as of September 21, 2023, and is entered into by and between ZIC 1212 Terra Bella LLC, a Delaware limited liability company (“Lessor”), and IRIDEX CORPORATION, a Delaware corporation (“Lessee”), with regard to the following facts:
SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement • June 26th, 2019 • Iridex Corp • Electromedical & electrotherapeutic apparatus
This Separation Agreement and General Release (hereinafter referred to as “Agreement”) is made and entered into by and between William M. Moore (hereinafter referred to as “Executive”) and Iridex Corporation (hereinafter referred to as “Iridex” or “Company”).
